INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
05/08/2026
Voltar para busca
Dado oficial do USPTO
FECINOR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
05/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 31
Data de depósito
23/05/2017
Data de registro
21/05/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/12/2025
Última transação
05/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
DE
Examinador
PODESTA, GIDETTE
Unidade examinadora
N70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Evonik Operations GmbH
Evonik Degussa GmbH
Representantes
Scott D. Woldow SMITH, GAMBRELL, RUSSELL, LLP
Classificação técnica
Classes Nice
Classe 5Classe 31
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and veterinary preparations for the prevention and for the treatment of nutrition deficienciesintestinal healthdigestive health and stomach disorders; pharmaceutical and veterinary preparations for the prevention and treatment of bacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; pharmaceutical and veterinary preparations for the prevention and treatment of necrotic enteritis; diarrhea medication; pharmaceutical and veterinary preparations for the prevention and treatment of intestinal bacteria; pharmaceutical and veterinary preparations for the prevention and for the treatment of nutrition deficienciesintestinal healthdigestive health and stomach disorders containing Enterococcus faecium; veterinary pharmaceutical preparations for the prevention and for the treatment of probiotic deficiencies; veterinary preparationsfeeding stimulants for animals; medical and veterinary preparations for the prevention and for the treatment of nutrition deficienciesintestinal healthdigestive health and stomach disorders; medical and veterinary preparations for the prevention and for the treatment of bacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; medical and veterinary preparationsfodder acidifiers for medical purposes and fodder additives for medical purposes in form of amino acidspeptides and proteins and mixtures thereof; medical and veterinary preparations for the prevention and for the treatment of necrotic enteritis; medical and veterinary preparations for the prevention and for the treatment of intestinal bacteria; medical and veterinary preparations for the prevention and for the treatment of nutrition deficienciesintestinal healthdigestive health and stomach disorders containing Enterococcus faecium; chemical preparations for medicalpharmaceutical and veterinary purposes for the prevention and for the treatment of nutrition deficienciesintestinal healthdigestive health and stomach disorders; chemical preparations for medicalpharmaceutical and veterinary purposes for the prevention and for the treatment bacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; chemical preparations for medicalpharmaceutical and veterinary purposes for the prevention and for the treatment of necrotic enteritis; chemical preparations for medicalpharmaceutical and veterinary purposes for the prevention and for the treatment of intestinal bacteria; amino acids for medical and veterinary purposes; chemical preparations in the nature of estersmedicinal oils and greases for medical and veterinary purposes; saltsin particular potassium and sodium salts for medical purposes; saltsin particular potassium and sodium salts for veterinary medical purposes; steroids; ferments for pharmaceutical purposes; dietetic foodsyeast and starch for medical purposes; yeast and starch for pharmaceutical purposes; enzymes and enzyme preparations for medical and veterinary purposes; biological preparations for medical and veterinary purposesfor the prevention and for the treatment of nutrition deficienciesintestinal healthdigestive health and stomach disorders; bacteriological preparations for medical and veterinary purposes; cultures of microorganisms for medical and veterinary use; nutritive substances for microorganisms for medical purposes; bouillons for bacteriological cultures; dietetic food and substances adapted for medical or veterinary use; albuminous preparations for medical purposesalbumin dietary supplements; medicated confectionery in the nature of medicated candy; medicinal drinks; dietetic beverages adapted for medical purposes; medical preparations for slimming purposes; food for babies; nutritional supplements for humans; dietary supplements for animals; sugarin particular candy and glucose for medical purposes; glucose for medical purposes; protein dietary supplements; mineral food supplements; preparations of trace elements for human and animal usedietary supplements; vitamin preparations; animal feed supplementsnot for medical purposes; animal feed supplements in form of amino acidspeptides and proteins for animal feedfish food and aquacultures; animal feed supplementsnon-medicated additives for animal feed for use as nutritional supplements; probiotic supplements; probiotic animal feed; nutritional supplementsprobiotic compositions; micro-nutrient animal feed for fish and aquacultures; feed supplementssynthetic peptides for the treatment of nutrition deficiencies; protein supplements for animals; amino acids and peptides for nutritional purposes for use in animal feedfish food and aquaculture; feed supplements containing Enterococcus faecium
Classe 31
Agriculturalhorticultural and forestry products as well as products for aquacultureaquaculture feed; live animals; organisms for breedinglive animals; foodstuffs and fodder for animals; bedding for animalschopped straw for animal beddingcellulose for use as animal beddinglitter for animals; animal feed preparations; nutrients foodstuffs for fish and aquaculturesaquaculture feedfoodstuffs for fish; yeast for animal consumption
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
C71T
CANCELLED SECTION 71
05/12/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
21/05/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
05/08/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
27/09/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/09/2019
FIMP
FINAL DISPOSITION PROCESSED
10/09/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
21/08/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
21/05/2019
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
17/05/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/05/2019
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/03/2019
PUBO
PUBLISHED FOR OPPOSITION
05/03/2019
GPNX
NOTIFICATION PROCESSED BY IB
01/03/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13/02/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
13/02/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/02/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/01/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/01/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/01/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/07/2018
GNRT
NON-FINAL ACTION E-MAILED
21/07/2018
CNRT
NON-FINAL ACTION WRITTEN
21/07/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/06/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/06/2018
ALIE
ASSIGNED TO LIE
28/06/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/06/2018
RFNT
REFUSAL PROCESSED BY IB
19/01/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/12/2017
RFRR
REFUSAL PROCESSED BY MPU
27/12/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/12/2017
CNRT
NON-FINAL ACTION WRITTEN
12/12/2017
MAFR
APPLICATION FILING RECEIPT MAILED
12/12/2017
DOCK
ASSIGNED TO EXAMINER
08/12/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/12/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
30/11/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FECINOR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.